BACKGROUND: Immune-mediated neuropathies, such as chronic inflammatory demyelinating polyneuropathy (CIDP) are treatable neuropathies. Among individuals with diabetic neuropathy, it remains a challenge to identify those individuals who develop CIDP. Corneal confocal microscopy (CCM) has been shown to detect corneal nerve fiber loss and cellular infiltrates in the sub-basal layer of the cornea. The objective of the study was to determine whether CCM can distinguish diabetic neuropathy from CIDP and whether CCM can detect CIDP in persons with coexisting diabetes. METHODS: In this multicenter, case-control study, participants with CIDP (n = 55) with (n = 10) and without (n = 45) diabetes; participants with diabetes (n = 58) with (n = 28) and without (n = 30) diabetic neuropathy, and healthy controls (n = 58) underwent CCM. Corneal nerve fiber density (CNFD), corneal nerve fiber length (CNFL), corneal nerve branch density (CNBD), and dendritic and non-dendritic cell density, with or without nerve fiber contact were quantified. RESULTS: Dendritic cell density in proximity to corneal nerve fibers was significantly higher in participants with CIDP with and without diabetes compared to participants with diabetic neuropathy and controls. CNFD, CNFL, and CNBD were equally reduced in participants with CIDP, diabetic neuropathy, and CIDP with diabetes. CONCLUSIONS: An increase in dendritic cell density identifies persons with CIDP. CCM may, therefore, be useful to differentiate inflammatory from non-inflammatory diabetic neuropathy.

Brain and Mind Centre University of Sydney Sydney Australia

Department of Cardiology University Hospital Essen University Duisburg Essen Essen Germany

Department of Neurology and Center for Translational and Behavioral Neurosciences University Hospital Essen University Duisburg Essen Essen Germany

Department of Neurology Medical Faculty Heinrich Heine University Düsseldorf Germany

Department of Neurology Palacky University Olomouc Czech Republic

Institute of Cardiovascular Science Faculty of Medical and Human Sciences University of Manchester Manchester UK

Medical University Vienna Vienna Austria

Weill Cornell Medicine Qatar Educator City Doha Qatar

See more in PubMed

Querol L, Crabtree M, Herepath M, Priedane E, Viejo Viejo I, Agush S, Sommerer P. 2020. Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol PubMed

McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. 1999;46(6):910–3. 10.1002/1531-8249(199912)46:6<910::AID-ANA14>3.0.CO;2-2. PubMed

Chaudhary UJ, Rajabally YA. 2020. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy. J Neurol, DOI: 10.1007/s00415-020-10287-7 PubMed PMC

Liberatore G, Manganelli F, Doneddu PE, Cocito D, Fazio R, Briani C, Filosto M, Benedetti L, Mazzeo A, Antonini G, Cosentino G, Jann S, Cortese A, Marfia GA, Clerici AM, Siciliano G, Carpo M, Luigetti M, Lauria G, Rosso T, Cavaletti G, Santoro L, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Schenone A, Leonardi L, Toscano A, Mataluni G, Spina E, Gentile L, Nobile-Orazio E. 2020. Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? Eur J Neurol PubMed

Stino AM, Naddaf E, Dyck PJ, Dyck PJB. 2020. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. Muscle Nerve PubMed

Rajabally YA, Stettner M, Kieseier BC, Hartung HP, Malik RA. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management. Nat Rev Neurol. 2017;13(10):599–611. doi: 10.1038/nrneurol.2017.123. PubMed DOI

Doneddu PE, Cocito D, Manganelli F, Fazio R, Briani C, Filosto M, Benedetti L, Bianchi E, Jann S, Mazzeo A, Antonini G, Cosentino G, Marfia GA, Cortese A, Clerici AM, Carpo M, Schenone A, Siciliano G, Luigetti M, Lauria G, Rosso T, Cavaletti G, Beghi E, Liberatore G, Santoro L, Spina E, Peci E, Tronci S, Ruiz M, Cotti Piccinelli S, Verrengia EP, Gentile L, Leonardi L, Mataluni G, Piccolo L, Nobile-Orazio E. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy. J Neurol Neurosurg Psychiatry. 2020;91(10):1092–1099. doi: 10.1136/jnnp-2020-323615. PubMed DOI

Efron N, Edwards K, Roper N, Pritchard N, Sampson GP, Shahidi AM, Vagenas D, Russell A, Graham J, Dabbah MA, Malik RA. Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes. Eye Contact Lens. 2010;36(5):245–248. doi: 10.1097/ICL.0b013e3181eea915. PubMed DOI

Hertz P, Bril V, Orszag A, Ahmed A, Ng E, Nwe P, Ngo M, Perkins BA. Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diab Med. 2011;28(10):1253–1260. doi: 10.1111/j.1464-5491.2011.03299.x. PubMed DOI

Smith AG, Kim G, Porzio M, Allen B, Koach M, Mifflin M, Digre K, Keung BM, Singleton JR. Corneal confocal microscopy is efficient, well-tolerated, and reproducible. J Peripheral Nervous Syst. 2013;18(1):54–58. doi: 10.1111/jns5.12008. PubMed DOI

Malik RA, Kallinikos P, Abbott CA, van Schie CH, Morgan P, Efron N, Boulton AJ. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia. 2003;46(5):683–688. doi: 10.1007/s00125-003-1086-8. PubMed DOI

Perkins BA, Lovblom LE, Bril V, Scarr D, Ostrovski I, Orszag A, Edwards K, Pritchard N, Russell A, Dehghani C, Pacaud D, Romanchuk K, Mah JK, Jeziorska M, Marshall A, Shtein RM, Pop-Busui R, Lentz SI, Boulton AJM, Tavakoli M, Efron N, Malik RA. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study. Diabetologia. 2018;61(8):1856–1861. doi: 10.1007/s00125-018-4653-8. PubMed DOI PMC

Ferdousi M, Kalteniece A, Azmi S, Petropoulos IN, Ponirakis G, Alam U, Asghar O, Marshall A, Fullwood C, Jeziorska M, Abbott C, Lauria G, Faber CG, Soran H, Efron N, Boulton AJM, Malik RA. 2020. Diagnosis of neuropathy and risk factors for corneal nerve loss in type 1 and type 2 diabetes: a corneal confocal microscopy study. Diabetes Care PubMed PMC

Chen X, Graham J, Dabbah MA, Petropoulos IN, Ponirakis G, Asghar O, Alam U, Marshall A, Fadavi H, Ferdousi M, Azmi S, Tavakoli M, Efron N, Jeziorska M, Malik RA. Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density. Diab Care. 2015;38(6):1138–1144. doi: 10.2337/dc14-2422. PubMed DOI PMC

Pritchard N, Edwards K, Russell AW, Perkins BA, Malik RA, Efron N. Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes. Diab Care. 2015;38(4):671–675. doi: 10.2337/dc14-2114. PubMed DOI

Tavakoli M, Marshall A, Pitceathly R, Fadavi H, Gow D, Roberts ME, Efron N, Boulton AJ, Malik RA. Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol. 2010;223(1):245–250. doi: 10.1016/j.expneurol.2009.08.033. PubMed DOI PMC

Tavakoli M, Marshall A, Banka S, Petropoulos IN, Fadavi H, Kingston H, Malik RA. Corneal confocal microscopy detects small-fiber neuropathy in Charcot-Marie-Tooth disease type 1A patients. Muscle Nerve. 2012;46(5):698–704. doi: 10.1002/mus.23377. PubMed DOI PMC

Kemp HI, Petropoulos IN, Rice ASC, Vollert J, Maier C, Sturm D, Schargus M, Peto T, Hau S, Chopra R, Malik RA. Use of Corneal Confocal Microscopy to Evaluate Small Nerve Fibers in Patients With Human Immunodeficiency Virus. JAMA Ophthalmol. 2017;135(7):795–800. doi: 10.1001/jamaophthalmol.2017.1703. PubMed DOI PMC

Ferdousi M, Azmi S, Petropoulos IN, Fadavi H, Ponirakis G, Marshall A, Tavakoli M, Malik I, Mansoor W, Malik RA. Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy. PLoS One. 2015;10(10):e0139394. doi: 10.1371/journal.pone.0139394. PubMed DOI PMC

Rousseau A, Cauquil C, Dupas B, Labbé A, Baudouin C, Barreau E, Théaudin M, Lacroix C, Guiochon-Mantel A, Benmalek A, Labetoulle M, Adams D. Potential role of in vivo confocal microscopy for imaging corneal nerves in transthyretin familial amyloid polyneuropathy. JAMA Ophthalmol. 2016;134:983–989. doi: 10.1001/jamaophthalmol.2016.1889. PubMed DOI

Pagovich OE, Vo ML, Zhao Z, Petropoulos IN, Yuan M, Lertsuwanroj B, Ciralsky J, Lai E, Kiss S, D'Amico DJ, Mezey JG, Malik RA, Crystal RG. 2018. Corneal Confocal Microscopy: Neurologic Disease Biomarker in Friedreich's Ataxia. Ann Neurol PubMed

Leppin K, Behrendt AK, Reichard M, Stachs O, Guthoff RF, Baltrusch S, Eule JC, Vollmar B. Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the cornea. Invest Ophthalmol Vis Sci. 2014;55(6):3603–3615. doi: 10.1167/iovs.14-14307. PubMed DOI

Stettner M, Hinrichs L, Guthoff R, Bairov S, Petropoulos IN, Warnke C, Hartung HP, Malik RA, Kieseier BC. Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy. Ann Clin Transl Neurol. 2016;3(2):88–100. doi: 10.1002/acn3.275. PubMed DOI PMC

Pitarokoili K, Sturm D, Labedi A, Greiner T, Eitner L, Kumowski N, Enax-Krumova EK, Fisse AL, Maier C, Gold R, Tegenthoff M, Schmidt-Wilcke T, Yoon MS. Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy. Ther Adv Neurol Disord. 2019;12:1756286419855485. doi: 10.1177/1756286419855485. PubMed DOI PMC

Athanasopoulos D, Motte J, Fisse AL, Grueter T, Trampe N, Sturm D, Tegenthoff M, Sgodzai M, Klimas R, Querol L, Gold R, Pitarokoili K. Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy. Ann Clin Transl Neurol. 2020;7(6):1061–1068. doi: 10.1002/acn3.51061. PubMed DOI PMC

Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, Illa I, Koski CL, Leger JM, Nobile-Orazio E, Pollard J, Sommer C, Van den Bergh P, van Doorn PA, van Schaik IN. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13(4):326–332. doi: 10.1111/j.1468-1331.2006.01278.x. PubMed DOI

Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diab Care. 2010;33(10):2285–2293. doi: 10.2337/dc10-1303. PubMed DOI PMC

Rajabally YA, Peric S, Cobeljic M, Afzal S, Bozovic I, Palibrk A, Basta I. Chronic inflammatory demyelinating polyneuropathy associated with diabetes: a European multicentre comparative reappraisal. J Neurol Neurosurg Psychiatry. 2020;91(10):1100–1104. doi: 10.1136/jnnp-2020-322971. PubMed DOI

Lotan I, Hellman MA, Steiner I. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus. Acta Neurol Scand. 2015;132(4):278–283. doi: 10.1111/ane.12394. PubMed DOI

Dunnigan SK, Ebadi H, Breiner A, Katzberg HD, Lovblom LE, Perkins BA, Bril V. Conduction slowing in diabetic sensorimotor polyneuropathy. Diab Care. 2013;36(11):3684–3690. doi: 10.2337/dc13-0746. PubMed DOI PMC

Herrmann DN, Ferguson ML, Logigian EL. Conduction slowing in diabetic distal polyneuropathy. Muscle Nerve. 2002;26(2):232–237. doi: 10.1002/mus.10204. PubMed DOI

Dunnigan SK, Ebadi H, Breiner A, Katzberg HD, Lovblom LE, Perkins BA, Bril V. Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP. Brain Behav. 2013;3(6):656–663. doi: 10.1002/brb3.177. PubMed DOI PMC

Mitsuma S, Van den Bergh P, Rajabally YA, Van Parijs V, Martin-Lamb D, Sonoo M, Inaba A, Shimizu T, Isose S, Sato Y, Komori T, Misawa S, Kuwabara S. Effects of low frequency filtering on distal compound muscle action potential duration for diagnosis of CIDP: A Japanese-European multicenter prospective study. Clin Neurophysiol. 2015;126(9):1805–1810. doi: 10.1016/j.clinph.2014.11.027. PubMed DOI

Rajabally YA, Martin-Lamb D, Nicolas G. Compound muscle action potential amplitude and distal potential duration in axonal neuropathy. Muscle Nerve. 2014;49(1):146–147. doi: 10.1002/mus.24065. PubMed DOI

Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, Sommer C. Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology. 2003;61(11):1607–1610. doi: 10.1212/01.WNL.0000096174.86850.7F. PubMed DOI

Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology. 2005;65(12):1924–1929. doi: 10.1212/01.wnl.0000188879.19900.b7. PubMed DOI

Mayer WJ, Mackert MJ, Kranebitter N, Messmer EM, Gruterich M, Kampik A, Kook D. Distribution of antigen presenting cells in the human cornea: correlation of in vivo confocal microscopy and immunohistochemistry in different pathologic entities. Curr Eye Res. 2012;37(11):1012–1018. doi: 10.3109/02713683.2012.696172. PubMed DOI

Chen W, Hara K, Tian Q, Zhao K, Yoshitomi T. Existence of small slow-cycling Langerhans cells in the limbal basal epithelium that express ABCG2. Exp Eye Res. 2007;84(4):626–634. doi: 10.1016/j.exer.2006.11.006. PubMed DOI

Mayer WJ, Irschick UM, Moser P, Wurm M, Huemer HP, Romani N, Irschick EU. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci. 2007;48(10):4459–4467. doi: 10.1167/iovs.06-1184. PubMed DOI

Alkhawajah NM, Dunnigan SK, Bril V. Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients. J Neurol. 2014;261(8):1485–1491. doi: 10.1007/s00415-014-7357-0. PubMed DOI PMC

Nabi S, Kahlon P, Bozorgnia F, Arshad A, Saleem A, Kuriakose P. Analyzing Relationship Between Monoclonal Gammopathy of Undetermined Significance (MGUS) with Different Types of Neuropathy: An Observational Study. Indian J Hematol Blood Transfus. 2016;32(2):186–192. doi: 10.1007/s12288-015-0547-9. PubMed DOI PMC

Magy L, Chassande B, Maisonobe T, Bouche P, Vallat JM, Leger JM. Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases. Eur J Neurol. 2003;10(6):677–685. doi: 10.1046/j.1468-1331.2003.00687.x. PubMed DOI